Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients

NCT00241462 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00241462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00241462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Terminated
Start date
June 30, 2005
Completion date
December 31, 2009
Enrollment
150 (estimated)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer